Mazabraud Yann bought RYTM
March 2, 2026 · Form 4 insider transaction
Mazabraud Yann bought 35,000 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,000
Price
$0.00
Total value
N/A
InsiderMazabraud Yann
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after35,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options were granted on March 2, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.